Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Colorectal Neoplasms

  Free Subscription

Articles published in J Pathol

Retrieve available abstracts of 22 articles:
HTML format

Single Articles

    February 2023
  1. CAI H, Feng X, Yin R, Zhao Y, et al
    MIST: multiple instance learning network based on Swin Transformer for whole slide image classification of colorectal adenomas.
    J Pathol. 2023;259:125-135.
    PubMed     Abstract available

    January 2023
  2. PETROPOULOS M, Champeris Tsaniras S, Nikou S, Maxouri S, et al
    Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage.
    J Pathol. 2023;259:10-20.
    PubMed     Abstract available

    December 2022
  3. WANG W, Zhu X, Zhang X, Lei C, et al
    Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
    J Pathol. 2022 Dec 27. doi: 10.1002/path.6047.
    PubMed     Abstract available

    November 2022
  4. ZHANG J, Chen B, Li H, Wang Y, et al
    Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
    J Pathol. 2022 Nov 14. doi: 10.1002/path.6033.
    PubMed     Abstract available

    August 2022
  5. PAVLIC A, Bostjancic E, Kavalar R, Ilijevec B, et al
    Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
    J Pathol. 2022 Aug 6. doi: 10.1002/path.5998.
    PubMed     Abstract available

    July 2022
  6. GLAIRE MA, Ryan NA, Ijsselsteijn ME, Kedzierska K, et al
    Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
    J Pathol. 2022;257:340-351.
    PubMed     Abstract available

    June 2022
  7. KLAPHOLZ M, Drage MG, Srivastava A, Anderson AC, et al
    Presence of Tim3(+) and PD-1(+) CD8(+) T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features.
    J Pathol. 2022;257:186-197.
    PubMed     Abstract available

    May 2022
  8. KUMAR N, Verma R, Chen C, Lu C, et al
    Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
    J Pathol. 2022;257:17-28.
    PubMed     Abstract available

    April 2022
  9. BOSCH TVD, Miedema DM, Vermeulen L
    Copy-number heterogeneity as high-risk feature of stage II colon cancer.
    J Pathol. 2022 Apr 26. doi: 10.1002/path.5919.
    PubMed     Abstract available

  10. HEINZE K, Nazeran TM, Lee S, Kramer P, et al
    Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8(+) TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
    J Pathol. 2022;256:388-401.
    PubMed     Abstract available

    February 2022
  11. BLEIJENBERG AGC, IJspeert JEG, Mulder JBG, Drillenburg P, et al
    The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
    J Pathol. 2022 Feb 10. doi: 10.1002/path.5881.
    PubMed     Abstract available

    January 2022
  12. LAHOZ S, Archilla I, Asensio E, Hernandez-Illan E, et al
    Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.
    J Pathol. 2022 Jan 23. doi: 10.1002/path.5870.
    PubMed     Abstract available

  13. YAMAMOTO D, Oshima H, Wang D, Takeda H, et al
    Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    J Pathol. 2022 Jan 17. doi: 10.1002/path.5868.
    PubMed     Abstract available

  14. SCHRAMMEN PL, Ghaffari Laleh N, Echle A, Truhn D, et al
    Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology.
    J Pathol. 2022;256:50-60.
    PubMed     Abstract available

    December 2021
  15. STEHR AM, Wang G, Demmler R, Stemmler MP, et al
    Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer.
    J Pathol. 2021 Dec 23. doi: 10.1002/path.5860.
    PubMed     Abstract available

    Untangling the complexities of micropapillary cancer(dagger).
    J Pathol. 2021;255:343-345.
    PubMed     Abstract available

  17. CERRETELLI G, Zhou Y, Muller MF, Adams DJ, et al
    Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.
    J Pathol. 2021;255:464-474.
    PubMed     Abstract available

  18. KIM JH, Hong JH, Choi YL, Lee JA, et al
    NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    J Pathol. 2021;255:399-411.
    PubMed     Abstract available

    November 2021
  19. BROCKMOELLER S, Echle A, Laleh NG, Eiholm S, et al
    Deep Learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer.
    J Pathol. 2021 Nov 5. doi: 10.1002/path.5831.
    PubMed     Abstract available

    October 2021
  20. OHSHIMA K, Oi R, Nojima S, Morii E, et al
    Mitochondria govern histone acetylation in colorectal cancer.
    J Pathol. 2021 Oct 26. doi: 10.1002/path.5818.
    PubMed     Abstract available

    September 2021
  21. ONUMA K, Sato Y, Okuyama H, Uematsu H, et al
    Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma.
    J Pathol. 2021;255:84-94.
    PubMed     Abstract available

    May 2021
  22. KRAUSE J, Grabsch HI, Kloor M, Jendrusch M, et al
    Deep learning detects genetic alterations in cancer histology generated by adversarial networks.
    J Pathol. 2021;254:70-79.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.